Kilitch Drugs (India) Limited (KILITCH) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Kilitch Drugs (India) Limited (KILITCH) has a cash flow conversion efficiency ratio of -0.025x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-66.20 Million ≈ $-715.95K USD) by net assets (Rs2.64 Billion ≈ $28.57 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see KILITCH company net worth for the company's overall valuation and market capitalisation.
Kilitch Drugs (India) Limited - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Kilitch Drugs (India) Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Kilitch Drugs (India) Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kilitch Drugs (India) Limited ranked by their cash flow conversion efficiency. Explore Kilitch Drugs (India) Limited cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
S Connect Co. LTD
KQ:096630
|
0.101x |
|
Deutsch Motors Inc
KQ:067990
|
0.066x |
|
Thanh Cong Textile Garment Investment Trading JSC
VN:TCM
|
0.042x |
|
Future Vision II Acquisition Corporation Ordinary shares
NASDAQ:FVN
|
-0.270x |
|
SEWON Precision Industry Co., Ltd.
KO:021820
|
-0.022x |
|
The State Trading Corporation of India Limited
NSE:STCINDIA
|
0.000x |
|
Arena Group Holdings Inc
NYSE MKT:AREN
|
-2.718x |
|
Taeyang Metal
KO:004100
|
0.052x |
Annual Cash Flow Conversion Efficiency for Kilitch Drugs (India) Limited (2006–2025)
The table below shows the annual cash flow conversion efficiency of Kilitch Drugs (India) Limited from 2006 to 2025. View KILITCH share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs2.00 Billion ≈ $21.68 Million |
Rs175.42 Million ≈ $1.90 Million |
0.088x | +10608.11% |
| 2024-03-31 | Rs1.76 Billion ≈ $19.00 Million |
Rs-1.46 Million ≈ $-15.82K |
-0.001x | -104.85% |
| 2023-03-31 | Rs1.51 Billion ≈ $16.28 Million |
Rs25.86 Million ≈ $279.64K |
0.017x | -58.34% |
| 2022-03-31 | Rs1.40 Billion ≈ $15.17 Million |
Rs57.83 Million ≈ $625.41K |
0.041x | -88.31% |
| 2021-03-31 | Rs1.29 Billion ≈ $14.00 Million |
Rs456.59 Million ≈ $4.94 Million |
0.353x | +1034.35% |
| 2020-03-31 | Rs1.20 Billion ≈ $13.03 Million |
Rs37.45 Million ≈ $405.02K |
0.031x | +1216.09% |
| 2019-03-31 | Rs1.23 Billion ≈ $13.32 Million |
Rs2.91 Million ≈ $31.46K |
0.002x | -81.28% |
| 2018-03-31 | Rs1.13 Billion ≈ $12.19 Million |
Rs14.23 Million ≈ $153.90K |
0.013x | +13.89% |
| 2017-03-31 | Rs1.01 Billion ≈ $10.94 Million |
Rs11.21 Million ≈ $121.28K |
0.011x | -93.01% |
| 2016-03-31 | Rs1.09 Billion ≈ $11.75 Million |
Rs172.33 Million ≈ $1.86 Million |
0.159x | +349.49% |
| 2015-03-31 | Rs1.20 Billion ≈ $12.96 Million |
Rs-76.18 Million ≈ $-823.90K |
-0.064x | +75.42% |
| 2014-03-31 | Rs1.20 Billion ≈ $13.00 Million |
Rs-310.84 Million ≈ $-3.36 Million |
-0.259x | -2155.68% |
| 2013-03-31 | Rs1.19 Billion ≈ $12.88 Million |
Rs14.97 Million ≈ $161.93K |
0.013x | +104.95% |
| 2012-03-31 | Rs1.16 Billion ≈ $12.50 Million |
Rs-293.49 Million ≈ $-3.17 Million |
-0.254x | -217.16% |
| 2011-03-31 | Rs858.72 Million ≈ $9.29 Million |
Rs186.05 Million ≈ $2.01 Million |
0.217x | +3.92% |
| 2010-03-31 | Rs740.88 Million ≈ $8.01 Million |
Rs154.46 Million ≈ $1.67 Million |
0.208x | +27.83% |
| 2009-03-31 | Rs643.97 Million ≈ $6.96 Million |
Rs105.03 Million ≈ $1.14 Million |
0.163x | +120.74% |
| 2008-03-31 | Rs513.18 Million ≈ $5.55 Million |
Rs-403.48 Million ≈ $-4.36 Million |
-0.786x | -189.85% |
| 2007-03-31 | Rs135.84 Million ≈ $1.47 Million |
Rs118.87 Million ≈ $1.29 Million |
0.875x | +22.51% |
| 2006-03-31 | Rs116.74 Million ≈ $1.26 Million |
Rs83.39 Million ≈ $901.79K |
0.714x | -- |
About Kilitch Drugs (India) Limited
Kilitch Drugs (India) Limited engages in the development and operation of the pharmaceutical business in India and internationally. The company offers various parenteral, nasal, and topical products, such as liquid ampoules, vials, dry powder injectables, and metered nasal drops for gastroenterology, non-steroidal anti-inflammatory, anticonvulsant/antiepileptic, anti-malarial, aminoglycoside, ant… Read more